Company intelligence / Profile preview
Landsteiner Scientific
Ciudad de Mexico, Mexicolandsteiner.com ↗
- Ownership
- Private
- Employees
- ~750
- Development stage
- Commercial
01
Overview
Landsteiner Scientific has at least 4 approved products, including biosimilars for Interferon alfa-2b and Filgrastim
- Therapeutic areas
- OncologyImmunologyHematologyNeurologyInfectious Diseases
- Modalities
- Generic medicinesBiosimilarsBiotechnological productsGenomic medicine
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Joint Venture with CV Directo (leading direct sales company in Mexico)
Beyond the preview
Go deeper on Landsteiner Scientific.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Landsteiner Scientific.